147 related articles for article (PubMed ID: 7857591)
21. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on striatal tyrosine hydroxylase and tryptophan hydroxylase in rat.
Matsuda LA; Schmidt CJ; Hanson GR; Gibb JW
Neuropharmacology; 1986 Mar; 25(3):249-55. PubMed ID: 2871513
[TBL] [Abstract][Full Text] [Related]
22. Differential recovery of dopamine synthetic enzymes following MPTP and the consequences of GM1 ganglioside treatment.
Hadjiconstantinou M; Neff NH
Eur J Pharmacol; 1990 May; 181(1-2):137-9. PubMed ID: 1974854
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of [3H]dopamine uptake into striatal synaptosomes by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
McNaught KS; Thull U; Carrupt PA; Altomare C; Cellamare S; Carotti A; Testa B; Jenner P; Marsden CD
Biochem Pharmacol; 1996 Jul; 52(1):29-34. PubMed ID: 8678905
[TBL] [Abstract][Full Text] [Related]
24. Persistent depletion of striatal dopamine and cortical norepinephrine in mice by 1-methyl-4-phenyl-1,2,3,6-tetrahydro-3-pyridinol (MPTP-3-OL), an analog of MPTP.
Hemrick-Luecke SK; Robertson DW; Krushinski JH; Fuller RW
Life Sci; 1992; 50(8):573-82. PubMed ID: 1736028
[TBL] [Abstract][Full Text] [Related]
25. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correspondence of its binding sites to monoamine oxidase in rat brain, and inhibition of dopamine oxidative deamination in vivo and in vitro.
Bocchetta A; Piccardi MP; Del Zompo M; Pintus S; Corsini GU
J Neurochem; 1985 Sep; 45(3):673-6. PubMed ID: 3928808
[TBL] [Abstract][Full Text] [Related]
26. Enhancement of dopamine release in vivo from the rat striatum by dialytic perfusion of 6R-L-erythro-5,6,7,8-tetrahydrobiopterin.
Koshimura K; Miwa S; Lee K; Fujiwara M; Watanabe Y
J Neurochem; 1990 Apr; 54(4):1391-7. PubMed ID: 1968962
[TBL] [Abstract][Full Text] [Related]
27. The effects of L-deprenyl treatment, alone and combined with GM1 ganglioside, on striatal dopamine content and substantia nigra pars compacta neurons.
Rothblat DS; Schneider JS
Brain Res; 1998 Jan; 779(1-2):226-30. PubMed ID: 9473679
[TBL] [Abstract][Full Text] [Related]
28. Effects of nomifensine and its metabolites on dihydropteridine reductase.
Shen RS; Sheng WL; Abell CW
J Pharm Pharmacol; 1984 Jun; 36(6):411-3. PubMed ID: 6146678
[TBL] [Abstract][Full Text] [Related]
29. Is dopamine-induced inhibition of adenylate cyclase involved in the autoreceptor-mediated negative control of tyrosine hydroxylase in striatal dopaminergic terminals?
el Mestikawy S; Hamon M
J Neurochem; 1986 Nov; 47(5):1425-33. PubMed ID: 2876053
[TBL] [Abstract][Full Text] [Related]
30. Disposition of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mice before and after monoamine oxidase and catecholamine reuptake inhibition.
Lydén-Sokolowski A; Larsson BS; Lindquist NG
Pharmacol Toxicol; 1988 Aug; 63(2):75-80. PubMed ID: 3141911
[TBL] [Abstract][Full Text] [Related]
31. The ex vivo effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on rat intra- and extraneuronal monoamine oxidase activity.
Arai Y; Toyoshima Y; Kinemuchi H; Tadano T; Kisara K
Neurosci Lett; 1986 Oct; 70(2):266-71. PubMed ID: 3490638
[TBL] [Abstract][Full Text] [Related]
32. Alteration of dopamine synthesis in rat striatum subsequent to selective type A monoamine oxidase inhibition.
Schoepp DD; Azzaro AJ
J Neurochem; 1981 Aug; 37(2):527-30. PubMed ID: 6790675
[TBL] [Abstract][Full Text] [Related]
33. Monoamine oxidase-inhibition and MPTP-induced neurotoxicity in the non-human primate: comparison of rasagiline (TVP 1012) with selegiline.
Kupsch A; Sautter J; Götz ME; Breithaupt W; Schwarz J; Youdim MB; Riederer P; Gerlach M; Oertel WH
J Neural Transm (Vienna); 2001; 108(8-9):985-1009. PubMed ID: 11716151
[TBL] [Abstract][Full Text] [Related]
34. Dopamine autoreceptor regulation of the kinetic state of striatal tyrosine hydroxylase.
Strait KA; Kuczenski R
Mol Pharmacol; 1986 Jun; 29(6):561-9. PubMed ID: 2872588
[TBL] [Abstract][Full Text] [Related]
35. Metabolism of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in a rat pheochromocytoma cell line, PC12h.
Naoi M; Takahashi T; Nagatsu T
Life Sci; 1987 Dec; 41(24):2655-61. PubMed ID: 3121966
[TBL] [Abstract][Full Text] [Related]
36. Importance of monoamine oxidase A in the bioactivation of neurotoxic analogs of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Heikkila RE; Kindt MV; Sonsalla PK; Giovanni A; Youngster SK; McKeown KA; Singer TP
Proc Natl Acad Sci U S A; 1988 Aug; 85(16):6172-6. PubMed ID: 3137566
[TBL] [Abstract][Full Text] [Related]
37. Neuroprotective rather than neurorescue or neurorestorative effect of selegiline against MPTP-induced dopaminergic toxicity.
Wu WR; Zhu XZ; Guan HJ; Wang RG; Ji XQ
Zhongguo Yao Li Xue Bao; 1999 Feb; 20(2):146-50. PubMed ID: 10437162
[TBL] [Abstract][Full Text] [Related]
38. Amphetamine-metabolites of deprenyl involved in protection against neurotoxicity induced by MPTP and 2'-methyl-MPTP.
Sziráki I; Kardos V; Patthy M; Pátfalusi M; Gaál J; Solti M; Kollár E; Singer J
J Neural Transm Suppl; 1994; 41():207-19. PubMed ID: 7931228
[TBL] [Abstract][Full Text] [Related]
39. Absence of spare autoreceptors regulating dopamine agonist inhibition of tyrosine hydroxylation in slices of rat striatum.
Bohmaker K; Puza T; Goldstein M; Meller E
J Pharmacol Exp Ther; 1989 Jan; 248(1):97-103. PubMed ID: 2563295
[TBL] [Abstract][Full Text] [Related]
40. Monoamine oxidase-dependent metabolism of dopamine in the striatum and substantia nigra of L-DOPA-treated monkeys.
Di Monte DA; DeLanney LE; Irwin I; Royland JE; Chan P; Jakowec MW; Langston JW
Brain Res; 1996 Oct; 738(1):53-9. PubMed ID: 8949927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
